| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2015-04-22 | Taxon Biosciences (USA - CA) | DuPont (USA - DE) | undisclosed | Technology - Services |
| 2015-04-21 | Mylan (USA - PA) | Teva Pharmaceutical Industries (Israel) | $ 40 billion | Generics |
| 2015-04-17 | BioOutsource (UK) | Sartorius Stedim Biotech (France) | undisclosed | CRO Technology - Services |
| 2015-04-13 | CAPP Medical (USA - CA) | Roche (Switzerland) | undisclosed | Cancer - Oncology Diagnostic |
| 2015-04-10 | Tanomed (Sweden) | Karo Bio (Sweden) | Infectious diseases |
|
| 2015-04-08 | Flexus Biosciences (USA - CA) | BMS (USA - NY) | $1.25 billion | Cancer - Oncology |
| 2015-04-01 | Salix Pharmaceuticals (USA - NC) | Valeant Pharmaceuticals (Canada) | $15.8 billion | Gastrointestinal diseases |
| 2015-04-01 | UCB's brands in India | Dr. Reddy’s (India) | €118 million | Allergic diseases Dermatological diseases Neurological diseases Respiratory diseases |
| 2015-03-30 | Omega Pharma (Belgium) | Perrigo (Ireland) | € 3.8 Billion | OTC |
| 2015-03-30 | Hyperion Therapeutics (USA - CA) | Horizon Pharma (Ireland) | $1.1 billion | Orphan drugs Rare diseases |
| 2015-03-30 | Auspex Pharmaceuticals (USA - CA) | Teva Pharmaceutical Industries (Israel) | $3.2 billion | |
| 2015-03-19 | XO1 Limited (UK) | JJanssen Pharmaceuticals, a J&J company (USA - NJ) | undisclosed | Cardiovascular diseases Hematological diseases |
| 2015-03-17 | T-Cell Factory (The Netherlands) | Kite Pharma (USA - CA) | €20 million | Cancer- Oncology cell therapy gene therapy production manufacturing |
| 2015-03-09 | Alkermes\' manufacturing facility in Gainesville (USA - GA) and global rights to meloxicam | Recro Pharma (USA - PA) | up to $ 120 million | Manufacturing CNS diseases |
| 2015-03-09 | MaSTherCell (Belgium) | Orgenesis (Israel/USA - NY) | $ 24.6 million | Manufacturing Production Technology - Services Regenerative Medicine |
| 2015-03-05 | Novartis’ entire RNAi research and development portfolio and associated assets (Switzerland) | Arrowhead Research Corporation (USA - CA) | $ 35 million | RNAi therapeutics |
| 2015-03-05 | Targacept (USA - NC) | Catalyst Biosciences (USA - CA) | Genetic diseases - Hematological diseases - Rare diseases |
|
| 2015-03-04 | SuppreMol (Germany) | Baxter (USA - IL) | € 200 million | Allergic diseases Autoimmune diseases |
| 2015-03-04 | 45% of the equity of Alkahest (USA - CA) | Grifols (Spain) | $50 million | CNS diseases Neurodegenerative diseases |
| 2015-02-26 | Anaconda Pharma (France) | Biota Pharmaceuticals (USA - GA) | up to $38 million | Infectious diseases |
